AEON Biopharma Inc. Class A Company Profile
NYSE: AEONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 2:21 PM ET
AEON Biopharma at a glance
AEON Biopharma Inc. Class A (NYSE: AEON) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Irvine, CA. AEON Biopharma is led by Mr. Robert Bancroft and employs about 8 people. At a market capitalization of $15.5 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001837607, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does AEON Biopharma do?
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
Business description based on the company's public filings.
Company information
- Legal name
- AEON Biopharma Inc. Class A
- Ticker
- NYSE: AEON
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Robert Bancroft
- Employees
- 8
- Headquarters
- 5 Park Plaza, Irvine, CA, United States
- Phone
- 949 354 6499
- Website
- aeonbiopharma.com
- Market cap
- $15.52M
- SEC CIK
- 0001837607
- Latest annual report
- 10-K · Mar 30, 2026
Companies similar to AEON Biopharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ACTUActuate Therapeutics Inc. | 0.6429 | -5.32% | $15.44M | vs AEON |
| DAREDare Bioscience Inc. | 0.7845 | +1.59% | $15.43M | vs AEON |
| KTTAPasithea Therapeutics Corp. | 0.4503 | +2.13% | $15.05M | vs AEON |
| PTNPalatin Technologies Inc. | 9.02 | +0.11% | $16.06M | vs AEON |
| ALLRAllarity Therapeutics Inc. | 1.01 | +2.86% | $16.07M | vs AEON |
| MRKRMarker Therapeutics Inc. | 0.9734 | +2.46% | $16.23M | vs AEON |
| RKTORocket One Inc. | 0.656 | +1.53% | $16.33M | vs AEON |
| LPCNLipocine Inc. | 1.77 | -8.57% | $14.55M | vs AEON |